News
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to
New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized
Pfizer Inc. (NYSE:PFE) today announced detailed results of the first study to show the burden of both invasive and non-invasive Group B Streptococcus infections (GBS) among hospitalized adults in
Chevron Announces First Quarter 2020 Results
Chevron Corporation (NYSE: CVX) today reported earnings of $3.6 billion ($1.93 per share - diluted) for first quarter 2020, compared with earnings of $2.6 billion ($1.39 per share - diluted) in the
American Express Chief Executive Officer to Participate in the Bernstein Annual Strategic Decisions Conference
American Express Company (NYSE:AXP) Chairman and Chief Executive Officer, Stephen J. Squeri, will participate in the Bernstein Annual Strategic Decisions Conference held virtually, on Thursday, May
Chevron Announces Quarterly Dividend
The Board of Directors of Chevron Corporation (NYSE: CVX) declared a quarterly dividend of one dollar and twenty-nine cents ($1.29) per share, payable June 10, 2020, to all holders of common stock
IBM Board Approves Increase in Quarterly Cash Dividend for the 25th Consecutive Year
The IBM (NYSE: IBM) board of directors today declared a regular quarterly cash dividend of $1.63 per common share, payable June 10, 2020 to stockholders of record as of May 8, 2020. Today’s
PFIZER REPORTS FIRST-QUARTER 2020 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain other components of
Microsoft: Mit "Coronavirus-Money" zum Krisengewinner!
Satya Nadella führt den Microsoft-Konzern (WKN: 870747) – das wertvollste Nasdaq-Unternehmen mit einer unglaublichen Marktkapitalisierung von 1.325 Milliarden US-Dollar – in eine glanzvolle Zukunft
American Express Reports First-Quarter Revenue of $10.3 Billion and Earnings Per Share of $0.41
American Express Company (NYSE: AXP) today reported first-quarter net income of $367 million, or $0.41 per share, compared with net income of $1.6 billion, or $1.80 per share, a year ago.
Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
The board of directors of Pfizer Inc. (NYSE:PFE) today declared a 38-cent second-quarter 2020 dividend on the company’s common stock, payable June 5, 2020 to shareholders of record at the close of
IBM Reports 2020 First-Quarter Results
IBM (NYSE:IBM) today announced first-quarter 2020 earnings results.
“IBM remains focused on helping our clients adapt to the immediate challenges of the COVID-19 pandemic, while we continue to
P&G Canada Steps Up to Join COVID-19 Relief Efforts
Today, P&G Canada and its brands announce donations totaling over $2.5 million in hygiene products, hand sanitizers, face masks and financial support to healthcare workers and Canadians impacted by
American Express to Audio Webcast Its Annual Meeting of Shareholders on May 5
American Express (NYSE: AXP) announced today that it is transitioning the format of its previously-scheduled annual shareholder meeting to a live audio webcast, which will be held on Tuesday, May
Chevron to Hold Virtual Stockholders Meeting
Chevron Corporation (NYSE: CVX) will hold a virtual annual stockholders’ meeting in place of an in-person event due to safety concerns related to the COVID-19 pandemic. The meeting will take place
Chevron Sells Azerbaijan Assets to MOL Hungarian Oil and Gas
Chevron Corporation (NYSE: CVX) announced today that its affiliate companies have sold their non-operating interests in the Azeri-Chirag-Deepwater Gunashli (ACG) oil fields (including interests in
American Express Declares Dividend on Series B and Series C Preferred Stock
American Express Company (NYSE: AXP) has declared the following dividends on the Company’s Series B and C Preferred Shares:
-
A quarterly dividend on the Company’s 5.200% Fixed Rate / Floating
IBM: 2020 Annual Meeting of Stockholders
IBM (NYSE:IBM) today announced additional information regarding its 2020 Annual Meeting of Stockholders. As previously announced, the Annual Meeting will be held on Tuesday, April 28, 2020, at
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Pfizer Inc. (NYSE: PFE) today announced important advances in the battle against the global COVID-19 pandemic.
As outlined in Pfizer’s five-point plan, the company has been collaborating across
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), and Pfizer Inc. (NYSE: PFE) today disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine
Corona-Krise: Diese Gewinner-Aktien sind die Virus-Profiteure
Die COVID-19-Pandemie hat den gesamten Erdball fest im Griff. Glücklicherweise helfen Dir einige unserer besten Unternehmen bei der Bewältigung der Situation. Diese werden wie aus den letzten Krisen
Portfoliocheck: Mit United Health spielt Andreas Halvorsen die Gesundheitskarte
U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment
Pfizer to Hold Virtual-Only 2020 Annual Meeting of Shareholders
Pfizer Inc. (NYSE: PFE) today announced that its 2020 Annual Meeting of Shareholders will be held in a virtual-only format due to continued public health concerns related to coronavirus / COVID-19
Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic
Pfizer Inc. (NYSE: PFE) and The Pfizer Foundation today announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19
Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar to MabThera® (rituximab), for the treatment